Moody National Bank Trust Division’s Ionis Pharmaceuticals IONS Stock Holding History

Moody National Bank Trust Division’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-36,852	Closed	-$2.27M	–	241
2014 Q4	$2.27M	Buy	36,852 +21,750	+144%	+$1.07M	0.15%	21
2014 Q3	$586K	Buy	15,102 +7,695	+104%	+$273K	0.04%	129
2014 Q2	$255K	Sell	7,407 -29,797	-80%	-$938K	0.02%	238
2014 Q1	$1.61M	Sell	37,204 -37,100	-50%	-$1.8M	0.11%	34
2013 Q4	$2.96M	Hold	74,304	–	–	0.2%	11
2013 Q3	$2.79M	Sell	74,304 -3,057	-4%	-$91.3K	0.22%	10
2013 Q2	$2.08M	Buy	+77,361	New	+$1.65M	0.16%	20

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Moody National Bank Trust Division's IONS Position: Q1 2015 in Review

Moody National Bank Trust Division sold out of Ionis Pharmaceuticals (IONS) in Q1 2015, closing a stake of 36,852 shares — an estimated $2.27M sold.

Moody National Bank Trust Division first reported a position in IONS in Q2 2013 and held it in 7 quarters. The position peaked at $2.96M in Q4 2013. 339 funds tracked by Wall St. Rank hold IONS as of Q1 2015.

Moody National Bank Trust Division reported no remaining Ionis Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Moody National Bank Trust Division sold 36,852 Ionis Pharmaceuticals shares in Q1 2015, an estimated $2.27M.
Moody National Bank Trust Division first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Moody National Bank Trust Division's Ionis Pharmaceuticals position peaked at $2.96M in Q4 2013.
339 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2015.

Based on Moody National Bank Trust Division's 13F filing for Q1 2015, filed 13 May 2015.